Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Express Scripts
Medtronic
Johnson and Johnson
Baxter

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Amerigen Pharms Ltd Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for AMERIGEN PHARMS LTD, and what generic and branded alternatives to AMERIGEN PHARMS LTD drugs are available?

AMERIGEN PHARMS LTD has twelve approved drugs.

There is one tentative approval on AMERIGEN PHARMS LTD drugs.

Summary for Amerigen Pharms Ltd
US Patents:0
Tradenames:12
Ingredients:12
NDAs:12

Drugs and US Patents for Amerigen Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amerigen Pharms Ltd NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203659-002 Apr 16, 2015 DISCN No No   Start Trial   Start Trial
Amerigen Pharms Ltd INDAPAMIDE indapamide TABLET;ORAL 075201-001 Dec 4, 1998 AB RX No No   Start Trial   Start Trial
Amerigen Pharms Ltd INDAPAMIDE indapamide TABLET;ORAL 075201-002 Dec 4, 1998 AB RX No No   Start Trial   Start Trial
Amerigen Pharms Ltd MIGLUSTAT miglustat CAPSULE;ORAL 208342-001 Apr 17, 2018 AB RX No No   Start Trial   Start Trial
Amerigen Pharms Ltd TEMOZOLOMIDE temozolomide CAPSULE;ORAL 203490-005 Jul 13, 2016 AB RX No No   Start Trial   Start Trial
Amerigen Pharms Ltd PENICILLAMINE penicillamine CAPSULE;ORAL 209921-001 May 7, 2019 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
Merck
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.